Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

Invictus MD Strategies Corp > What would you pay for this?
View:
Post by Kleptocracy on Dec 18, 2018 12:29pm

What would you pay for this?

If the financials they are about to report had revenues in the range of 20M-27M
and the next quarter had revenues of about 41M?
Comment by display_name on Dec 18, 2018 1:05pm
That would indicate ~ 0.35 sales/share in two quarters. Would expect resistance to be strong around 4x sales/share which would put significant resistance around the $1.42 level, but the whole sector is still in an early speculative growth phase so breaking that level would still offer the chance to find support around higher multiples, might be able to hit 2.14 6x p/s with good earnings to go with ...more  
Comment by ketchenergy on Dec 18, 2018 8:33pm
Investor deck has 6 million grams current production and have been shipping since rec start up. capacity goes to 18 million grams by h1/2019 ( not sure if thats sale ready by h1/19 or a grow cycle from h1/19) so from oct 2018 to next report mid dec ( last q was sept 14th) not sure what to expect from revenue? 6 million grams at $5 is 30million, then 18 million grams at $5, 90 million. With the ...more  
Comment by Tigerwoods3672 on Dec 18, 2018 9:08pm
Where would this stack out to other companies?
Comment by bullmarkets on Dec 18, 2018 9:43pm
Not very good — management is overcompensated — spend 15 million or so on gene. Check swaps , other promotion. It’s going to be big losses going forward.  And your sales numbers are insanely high.  
Comment by ketchenergy on Dec 19, 2018 9:31pm
Just a guess based on website information regarding current and future production, currently at 6000kg
Comment by MoneyIsComing on Dec 19, 2018 10:15pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities